Evnia’s Post

View organization page for Evnia, graphic

5,955 followers

#Friday_Evnia_Treats 𝘼𝙧𝙚 𝙮𝙤𝙪 𝙧𝙚𝙖𝙙𝙮? Does your agreement with your Notified Body cover your legacy devices? 𝘛𝘰𝘰 𝘰𝘧𝘵𝘦𝘯, 𝘸𝘦 𝘴𝘦𝘦 𝘮𝘢𝘯𝘶𝘧𝘢𝘤𝘵𝘶𝘳𝘦𝘳𝘴 𝘮𝘪𝘴𝘪𝘯𝘵𝘦𝘳𝘱𝘳𝘦𝘵𝘪𝘯𝘨 𝘢𝘯𝘥/𝘰𝘳 𝘰𝘷𝘦𝘳𝘴𝘪𝘮𝘱𝘭𝘪𝘧𝘺𝘪𝘯𝘨 𝘵𝘩𝘦 𝘳𝘦𝘲𝘶𝘪𝘳𝘦𝘮𝘦𝘯𝘵𝘴. 𝗙𝗼𝗿 𝗲𝘅𝗮𝗺𝗽𝗹𝗲, 𝗮𝗻 𝗮𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗻𝗼𝘁 𝘀𝘂𝗳𝗳𝗶𝗰𝗶𝗲𝗻𝘁 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗮 𝗠𝗗𝗥-𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝘁 #𝗤𝗠𝗦 𝗮𝗻𝗱 𝗮 𝘄𝗿𝗶𝘁𝘁𝗲𝗻 𝗮𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗡𝗕.  Reach out to Evnia if you need assistance to understand the eligibility criteria! ☢️☢️By Sep 26, 2024, manufacturers of legacy devices must have entered into a written agreement with a #notifiedbody for the conformity assessment of their medical device to leverage the extended transition periods under 2023/607. 📢 To benefit from the extended transition period, the prerequisites below apply: 📍the device continues to comply with Directive 93/42/EEC 📍 there are no significant changes in the design and intended purpose 📍the device does not present an unacceptable risk to the health or safety of patients, users, or other persons, or to other aspects of the protection of public health 📍𝘁𝗵𝗲 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗲𝗿 𝗵𝗮𝘀 𝗽𝘂𝘁 𝗶𝗻 𝗽𝗹𝗮𝗰𝗲 𝗮 #𝗾𝘂𝗮𝗹𝗶𝘁𝘆𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁𝘀𝘆𝘀𝘁𝗲𝗺 𝗶𝗻 𝗮𝗰𝗰𝗼𝗿𝗱𝗮𝗻𝗰𝗲 𝘄𝗶𝘁𝗵 #𝗠𝗗𝗥 𝗯𝘆 𝟮𝟲 𝗠𝗮𝘆 𝟮𝟬𝟮𝟰 𝗮𝘁 𝘁𝗵𝗲 𝗹𝗮𝘁𝗲𝘀𝘁 📍 the submission of a formal application to a Notified Body until 26 May 2024 at the latest and 𝘁𝗵𝗲 𝗰𝗼𝗻𝗰𝗹𝘂𝘀𝗶𝗼𝗻 𝗼𝗳 𝗮 𝗳𝗼𝗿𝗺𝗮𝗹 𝘄𝗿𝗶𝘁𝘁𝗲𝗻 𝗮𝗴𝗿𝗲𝗲𝗺𝗲𝗻𝘁 𝘂𝗻𝗱𝗲𝗿 𝗠𝗗𝗥 𝘂𝗻𝘁𝗶𝗹 𝟮𝟲 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟰. This agreement should cover the legacy device, or a device intended to substitute it. ☢️☢️ During the transition period, the devices will be surveilled. 𝗔 𝗠𝗗𝗥-𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝘁 #𝗽𝗼𝘀𝘁𝗺𝗮𝗿𝗸𝗲𝘁𝘀𝘂𝗿𝘃𝗲𝗶𝗹𝗹𝗮𝗻𝗰𝗲 𝘀𝘆𝘀𝘁𝗲𝗺 𝗺𝘂𝘀𝘁 𝗯𝗲 𝗶𝗻 𝗽𝗹𝗮𝗰𝗲. Starting 26 Sep. 2024, the surveillance will be carried out by the MDR-designated NB that has signed the written agreement. If this is different than the notified body that issued the #MDD certificate, a transfer agreement (‘tripartite agreement’) has to be signed to set the arrangements for the transfer of the surveillance. Read the reminder issued by BVMed - Bundesverband Medizintechnologie on the closing deadline: https://lnkd.in/gSvaA2sZ Q&A document issued by the European Commission:https://lnkd.in/dr_7cumM Transfer agreement template issued by Team-NB: https://lnkd.in/dxZ9UECt Read more: https://lnkd.in/g5xEU5Pd #medtechnews #medtech #cemark #cemarking

  • diagram, timeline
Mark Arnold FCMI FCILT CQP MCQI MRSC MIoL

Chartered Quality Professional, Solutions Delivery to Healthcare Distribution, Double Business Owner and DJ.

3mo

Until they extend grace periods and move the goalposts again. You and I remember the initial rollout of MDR, yet here we are seven years later and still it's not fully implemented.

Like
Reply

To view or add a comment, sign in

Explore topics